Loading clinical trials...
Loading clinical trials...
A Phase Ⅱ Randomized Controlled Trial to Compare Gefitinib With Docetaxel as Second-line Therapy for Advanced or Metastatic Non-squamous NSCLC Patients With Wild-type EGFR
Conditions
Interventions
Gefitinib
Docetaxel
Locations
1
China
Department of Respiratory Medicine, Peking Union Medical College Hospita
Beijing, Beijing Municipality, China
Start Date
December 1, 2012
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2014
Last Updated
December 24, 2012
NCT07190248
NCT06305754
NCT07100080
NCT07195695
NCT06357533
NCT06731413
Lead Sponsor
Peking Union Medical College Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions